Total planned funding: $459,928,512
Clear active filters
FHI 360
NGO
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $143,856,589 |
Zambia | $68,463,069 |
Mozambique | $60,960,786 |
Kenya | $37,613,614 |
Vietnam | $20,168,355 |
Tanzania | $13,751,848 |
South Africa | $11,244,893 |
Botswana | $11,059,397 |
Rwanda | $9,367,567 |
Namibia | $9,336,207 |
Burundi | $8,390,534 |
Ethiopia | $7,205,800 |
Côte d'Ivoire | $7,038,330 |
Guyana | $6,620,000 |
Papua New Guinea | $6,189,195 |
Indonesia | $5,176,155 |
India | $4,545,700 |
Haiti | $3,932,713 |
Asia Regional Program | $3,654,954 |
Democratic Republic of the Congo | $3,640,000 |
South Sudan | $2,751,916 |
Ghana | $2,750,000 |
Caribbean Region | $2,717,206 |
Malawi | $2,310,000 |
Central America Region | $1,646,143 |
Uganda | $1,618,804 |
Eswatini | $1,333,737 |
Angola | $1,085,000 |
Cameroon | $700,000 |
Dominican Republic | $500,000 |
Central Asia Region | $300,000 |
Lesotho | $0 |
Organizational Types
NGO | $459,928,512 |
Program Areas
Care | $110,796,168 |
Treatment | $100,919,739 |
Prevention | $97,875,332 |
Governance and Systems | $25,249,733 |
Testing | $21,712,459 |
Budget Codes
HTXS: Treatment: Adult Treatment | $88,432,302 |
HBHC: Care: Adult Care and Support | $55,792,085 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $52,229,951 |
HKID: Care: Orphans and Vulnerable Children | $35,951,627 |
HVOP: Sexual Prevention: Other Sexual Prevention | $29,964,658 |
HVCT: Testing: HIV Testing and Counseling | $21,712,459 |
PDTX: Treatment: Pediatric Treatment | $12,487,437 |
OHSS: Health Systems Strengthening | $10,376,329 |
HVTB: Care: TB/HIV | $10,273,628 |
PDCS: Care: Pediatric Care and Support | $8,778,828 |
HLAB: Laboratory Infrastructure | $7,673,084 |
HVSI: Strategic Information | $7,200,320 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $6,861,528 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $5,130,629 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,186,497 |
HMIN: Biomedical Prevention: Injection Safety | $403,324 |
HMBL: Biomedical Prevention: Blood Safety | $98,745 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$459,928,512
View countries